Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D.
Indian companies have made acquisitions of $1 billion so far in January
Real estate will prosper, small developers won't.
Most people have this permanent nervousness about somebody separating them from their smartphones.
An exchange which preaches others on governance must start practising it first, says Shyamal Majumdar.
The National Stock Exchange's proposed IPO to raise Rs 10,000 crore this year is expected to see the largest ever PE exit, of around Rs 5,000 crore.
Cross previous high of $72 billion in 2007 as Indian promoters overcome the selling taboo. Abhineet Kumar reports from Mumbai.
The trust deficit has widened with buyers losing confidence in a developer's ability to construct and deliver a project on time.
Accumulated sum Rs 31,500 crore in 2015-16
The venture is applying to the Reserve Bank of India for approvals.
Amendments to the Child Labour Act say children can work in 'family enterprises' but the definition isn't clear, points out Shyamal Majumdar.
The Aditya Birla Group announced the merger of its two holding companies, Aditya Birla Nuvo and Grasim, to make the holding structure clearer, ensure stable cash flows and unlock value in its financial services arm
Sixteen companies in the group registered a turnover of over $500 million, with ten of these registering a turnover of over $1 billion
The founders of Gland Pharma, led by Ravi Penmetsa, and KKR, together own 96 per cent of the company.
The government has to cover a lot of ground if it wants to achieve the target of generating 10 million new jobs in the sector over the next three years, says Shyamal Majumdar.
Indian carmakers will have no option but to manufacture safer cars from October 2017.
Ahmedabad-based firm to fund deal through equal amount of equity and debt.
Even if Modi had wanted Rajan out, the government could have done it with some finesse and tact.
How did the Kwid become an Indian success story?
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances